Increased proliferation and protein synthesis are characteristics of transformed and tumor cells. Although the components of the translation machinery are often dysregulated in cancer, the role of tRNAs in cancer cells has not been well studied. Nevertheless, the number of related studies has recently started increasing. With the development of high throughput technologies such as next-generation sequencing, genome-wide differential tRNA expression patterns in breast cancer–derived cell lines and breast tumors have been investigated. The genome-wide transcriptomics analyses have been linked with many studies for functional and phenotypic characterization, whereby tRNAs or tRNA-related fragments have been shown to play important roles in breast cancer regulation and as promising prognostic biomarkers. Here, we review their expression patterns, functions, prognostic value, and potential therapeutic use as well as related technologies.
|Title of host publication||Advances in Experimental Medicine and Biology|
|Number of pages||25|
|Publication status||Published - 2021|
|Name||Advances in Experimental Medicine and Biology|
Bibliographical notePublisher Copyright:
© Springer Nature Singapore Pte Ltd. 2021.
All Science Journal Classification (ASJC) codes
- Biochemistry, Genetics and Molecular Biology(all)